• © Jochen Kopp - research_tv
  • © Jochen Kopp - research_tv
  • © Jochen Kopp - research_tv
  • © Jochen Kopp - research_tv
  • © Jochen Kopp - research_tv

YaBiNaPA is supported by the DAAD with funds from the Federal Ministry for Economic Cooperation and Development (BMZ)

About YaBiNaPA

YaBiNaPA is the Yaoundé-Bielefeld Bilateral Graduate School for antiparasitic and antimicrobial Natural Products Discovery funded by DAAD to strengthen the capacity of Lecturers, Researchers (Master and PhD students) in the domain of phytomedicine for sustainable development in developing countries as planned by the 2030 agenda of UN on the theme «Transforming our World". Thus the Graduate School has the aim to provide specialized experts and lecturers with updated training at Masters, Doctorate, and Postdoc levels by making available its expertise, equipment, database and by organizing seminars, workshops and research stays in Germany and therefore move towards joint development and innovation.

Objective

The Yaoundé - Bielefeld Bilateral Graduate School "Natural Products with Antiparasite and Antibacterial Activity (YaBiNaPA)" intends to exert impact in three dimensions:

  • Improvement of Graduate Education: The network of scientists involved, together with improved technical resources and access to modern research technology will provide the members of the Graduate School with a broad scope of timely disciplinary and interdisciplinary skills.

  • Sustainability and translational research: The combination of the disciplines in relationship to potential application of natural products as isolated compounds or standardized extract preparations for therapeutic applications will confer the idea of translational research to the members of the Graduate School. The necessity of sustainable supply of plant derived natural products or extracts will be especially considered.

  • Improvement of quality of life: The joint research effort of the scientists from different disciplines is expected to lead to a progress in the therapy of parasitic or microbial diseases. Microbial infections and especially diseases like malaria and leishmaniosis require treatments that are affordable by the poorer population.